February 17, 2020 – 5:55 pm
Dr. Parker was invited to give a lecture at the MIT Science and Medicine Forum in October. Speakers were asked to choose “anything you want to talk about.” The audience was made up of MIT basic science researchers, medical doctors, and hospital administrators. I chose “Myomectomy, not Hysterectomy,” a topic that dominates my practice and […]
Dr. Parker has just written an article for OBG Management, a free OB-Gyn journal with the largest number of readers of all the OB-Gyn journals. In this article, Dr. Parker debunks the myths that gynecologists have been taught about myomectomy and the myths that women are often told as the reasons why they should have […]
January 29, 2016 – 11:42 pm
Jeffrey Shuren, M.D., J.D., the Director of the Center for Device and Radiological Health at the Food and Drug Administration, replied to an open letter from the Leiomyoma Morcellation Review Group. You can read the original open letter here, and view Dr. Shuren’s reply in the images below. The Leiomyoma Morcellation Review Group sent the […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged abdominal myomectomy, FDA, fibroid surgery, fibroids, Food and Drug Administration, laparoscopy, leiomyosarcoma, LMS, Morcellation, morcellation and cancer, morcellation risks, morcellator, ovarian cancer, power morcellation, power morcellator
|
December 8, 2015 – 5:00 pm
In November, 2014 the FDA ruled that power morcellation was contra-indicated in “the majority of women” having surgery for uterine fibroids due to the potential risk of spreading occult uterine sarcoma. Although problems with this ruling were immediately apparent, the passage of time has allowed for more clarity on the related medical issues. Prevalence of […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged abdominal myomectomy, FDA, fibroid surgery, fibroids, Food and Drug Administration, laparoscopy, leiomyosarcoma, LMS, Morcellation, morcellation and cancer, morcellation risks, morcellator, no hysterectomy, ovarian cancer, power morcellation, power morcellator
|
There is a lot of confusing information circulating about morcellation and uterine leiomyosarcoma in the media since the FDA hearing on this issue a few weeks ago. I plan to post my analysis of the information, in segments, over the next week or two. This first post provides commentary about the numbers used in research […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged FDA, fibroids, laparoscopy, LMS, Morcellation, morcellation risks, myomectomy, power morcellation, risk of LMS, risk of Uterine Leiomyosarcoma, robotic myomectomy, uterine leiomyosarcoma
|
Joan, San Diego I’ve been feeling frustrated and concerned about the upcoming FDA meeting later this week on the power morcellator. My fear is that the FDA panel will get a very slanted view of the situation because not enough woman who have benefited from minimally invasive gyn surgery using a morcellator can take the […]
By Bill Parker, MD
|
Posted in Recent Fibroid Research
|
Also tagged abdominal myomectomy, FDA, fibroids, focused ultrasound, Gynecologic Surgery, HIFU, hysteroscopic myomectomy, laparoscopic hysterectomy, minimally invasive surgery, Morcellation, morcellator, supra-cervial hysterectomy, UAE, uterine artery embolization
|
level of expertise and experience which will determine the largest size and the number of fibroids they are comfortable removing
February 27, 2011 – 2:03 pm
Hysterectomy should not be necessary and you should seek a second opinion from a gynecologist who can offer you the other options in order to see what is right for you.
Should I toughen up and just get the surgery or go for a pap smear and try to hold off for menopause.
December 10, 2009 – 2:16 pm
On November 19th, gynecologic surgeon William Parker, MD, performed live telesurgery from Saint John’s Health Center for the World Congress of Minimally Invasive Gynecology that was meeting in Orlando, Florida. The broadcast consisted of a laparoscopic myomectomy (remove uterine fibroids using a laparoscope) and was transmitted to an audience of over 1,000 gynecologists from over 60 countries who were attending the conference. See video here.
Disclaimer: The ideas, procedures and suggestions contained on this web site are not intended as a substitute for consulting with your physician. All matters regarding your health require medical supervision.